A naturally occurring compound found in cannabis may help curb the frequency of epileptic seizures, suggests a review of studies.
Epilepsy is a disorder in which nerve cell activity in the brain is disturbed, causing seizures.
The study, published in the Journal of Neurology Neurosurgery and Psychiatry, showed that Cannabidiol -- one of the cannabinoids found in cannabis -- was found more effective than a placebo drug at cutting seizure frequency by 50 per cent or more, and improving quality of life.
Cannabidiol has shown promising results, especially in children and teenagers, whose epilepsy does not respond to the conventional drugs, said the research led by Emily Stockings from the University of New South Wales in Australia.
Between 70 and 80 per cent of people newly diagnosed with epilepsy manage to control their seizures completely using conventional drugs such as valproate and carbamazepine.
But approximately one third of those diagnosed with serious conditions remain unresponsive to these treatments.
Of an initial haul of 91 studies, the researchers found six clinical trials (over 555 patients) and 30 observational studies (2,865 patients) that were eligible for inclusion in their review.
All the participants, whose average age was 16, had rare forms of epilepsy that had not responded to usual treatment.
The data showed that seizure frequency dropped by at least 50 per cent in just under half of the patients and disappeared completely in nearly one in 10 (8.5 per cent).
"Pharmaceutical grade Cannabidiol as adjuvant treatment in paediatric onset drug resistant epilepsy may reduce seizure frequency," the researchers said.
"The study was mostly in paediatric samples with rare and severe epilepsy syndromes, examining other syndromes and cannabinoids are needed."
--IANS
ng/rt/him/dg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
